A phase 2 study of venetoclax in combination with low-dose cytarabine in relapsing acute myeloid leukemia.

Wei, Andrew (Primary Chief Investigator (PCI))
Tiong, Ing Soo (Chief Investigator (CI))
Reynolds, John (Associate Investigator (AI))
Kennedy, Nola (Chief Investigator (CI))

Project: Research

Status	Active
Effective start/end date	22/09/19 → 31/12/24

Keywords

Acute Myeloid Leukemia
Malignant Haematology
Clinical trial